Status:
UNKNOWN
ID as a Promoter of IH-induced CAVD
Lead Sponsor:
Qilu Hospital of Shandong University
Conditions:
Iron Deficiencies
Calcified Aortic Valve
Eligibility:
All Genders
18+ years
Brief Summary
Calcific aortic valve disease (CAVD) is a highly prevalent, disabling and costly disorder with generally poor long-time outcomes once critical stenosis presents with symptoms. Elucidating viable thera...
Eligibility Criteria
Inclusion
- if performed with both color doppler echocardiography and anemia profile on admission as part of routine checkup.
Exclusion
- if younger than the age of 18;
- if no anemia profile or doppler echocardiography was measured;
- if anemia profile or doppler echocardiography was analyzed in external laboratories;
- if had a history of rheumatic heart disease, infective endocarditis or any other congenital disorders that may implicate aortic valve structures, such as bicuspid aortic valve morphology, Marfan syndrome, and so on.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT06200870
Start Date
January 1 2024
End Date
January 1 2024
Last Update
January 11 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.